280 related articles for article (PubMed ID: 12664784)
21. [Quantitative analysis of morphological manifestations of cholesterosis and concomitant pathology of the gall bladder].
Khomeriki SG; Orlova IuN; Il'chenko AA; Chikunova BZ; Chekmazov IA; Morozov IA
Arkh Patol; 2004; 66(5):12-5. PubMed ID: 15575378
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic efficacy of ursodeoxycholic acid in persistent gallbladder lithiasis and persistent biliary sludge: preliminary results of a multicenter experience].
Guma C; Viola L; Apestegui C; Pinchuk L; Groppa J; Michelini J; Martínez B; Bolaños R; Toselli L
Acta Gastroenterol Latinoam; 1994; 24(4):233-7. PubMed ID: 7701907
[TBL] [Abstract][Full Text] [Related]
23. [Indications for the medical gallstone dissolution].
Weis HJ
Fortschr Med; 1980 Sep; 98(33):1235-9. PubMed ID: 6780436
[TBL] [Abstract][Full Text] [Related]
24. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
[TBL] [Abstract][Full Text] [Related]
25. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
Goszcz A
Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
[No Abstract] [Full Text] [Related]
26. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
Lanzini A; Northfield TC
Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
[TBL] [Abstract][Full Text] [Related]
27. [Dissolution of biliary calculi with ursodeoxycholic acid: spectrographic study of undissolved calculi].
Ballesta-López C; Cabré Martínez C
Rev Esp Enferm Apar Dig; 1986 Jul; 70(1):37-41. PubMed ID: 3526447
[No Abstract] [Full Text] [Related]
28. [Effectiveness of ursodeoxycholic acid in cholesterosis of the gallbladder].
I'lchenko AA; Orlova IuN
Ter Arkh; 2003; 75(2):35-8. PubMed ID: 12685388
[TBL] [Abstract][Full Text] [Related]
29. [Does drug-induced litholysis still have a place in treatment of gallstones?].
Swobodnik W
Ther Umsch; 1993 Aug; 50(8):564-9. PubMed ID: 8211857
[TBL] [Abstract][Full Text] [Related]
30. Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.
Colombo C; Bertolini E; Assaisso ML; Bettinardi N; Giunta A; Podda M
Acta Paediatr; 1993; 82(6-7):562-5. PubMed ID: 8338990
[TBL] [Abstract][Full Text] [Related]
31. Effect of diet on dissolution of gallstones by ursodeoxycholic acid, including a comparison between ultrasonography and cholecystography.
Lefkof IR; Frenkiel PG; Lee DW; Cohen H; Bonorris GG; Gilmore CJ; Hamlin JA; Komaiko M; Resser K; Marks JW
Mt Sinai J Med; 1986 Apr; 53(4):241-9. PubMed ID: 3014318
[No Abstract] [Full Text] [Related]
32. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
[TBL] [Abstract][Full Text] [Related]
33. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
Ruppin DC; Murphy GM; Dowling RH
Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
[TBL] [Abstract][Full Text] [Related]
34. Cholelithiasis and acromegaly: therapeutic strategies.
Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G
Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305
[TBL] [Abstract][Full Text] [Related]
35. [Cholesteatosis of gallbladder (author's transl)].
Lehmann L; Kraus K
Zentralbl Chir; 1976; 101(14):848-54. PubMed ID: 973480
[TBL] [Abstract][Full Text] [Related]
36. Orally administered gallbladder therapeutic agents, Part II: Actigall (ursodeoxycholic Acid, UDCA).
Claussen DW
Gastroenterol Nurs; 1993 Jun; 15(6):254-5. PubMed ID: 8323995
[TBL] [Abstract][Full Text] [Related]
37. [Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment].
Lazebnik LB; Ovsiannikova ON; Zvenigorodskaia LA; Mel'nikova NV; Samsonova NG; Khomeriki SG
Ter Arkh; 2008; 80(1):57-61. PubMed ID: 18326230
[TBL] [Abstract][Full Text] [Related]
38. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
[TBL] [Abstract][Full Text] [Related]
39. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.
Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G
Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291
[TBL] [Abstract][Full Text] [Related]
40. [Influence of ursodeoxycholic acid on the immune status of patients with cholesterosis of gall-bladder depending on cholesterol index in blood].
Shcherbinina MB; Babets MI; Kudriavtseva VI
Eksp Klin Gastroenterol; 2014; (1):53-8. PubMed ID: 25518458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
